Resources | NITAG RESOURCE CENTER

2022 ∙ ATAGI

Novavax vaccine for adolescents aged 12-17 years

2022 ∙ ATAGI

ATAGI recommendations for use of Pfizer COVID-19 vaccine as a booster dose in adolescents aged 16-17 years

2022 ∙ ATAGI

ATAGI recommendations on the use of a booster dose of COVID-19 vaccine

2022 ∙ ATAGI

ATAGI statement on defining 'up-to-date' status for COVID-19 vaccination

2022 ∙ ATAGI

ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine

2022 ∙ ATAGI

ATAGI updated recommendations for a winter dose of COVID-19 vaccine

2022 ∙ ATAGI

Expanded ATAGI recommendations on winter COVID-19 booster doses for people at increased risk of severe COVID-19

2021 ∙ Wang, B. C. Chaiyakunapruk, N. Zhu, S. Babigumira, J. B. Furnback, W. Chitale, R. Gamil, A. Zhao, K. Wasserman, M.

A systematic literature review of economic evaluations of pneumococcal conjugate vaccines in east and southeast Asia (2006-2019)

2021 ∙ Ver, A. T. Notarte, K. I. Velasco, J. V. Buac, K. M. Nazareno, J., 3rd Lozanes, J. A. Antonio, D. Bacorro, W.

A systematic review of the barriers to implementing human papillomavirus vaccination programs in low- and middle-income countries in the Asia-Pacific

2021 ∙ Mungall, B. A. Kim, H. Oh, K. B.

A systematic review of the burden of pertussis in South Korea